CN100571795C - 机械性心衰脱水装置及其控制装置 - Google Patents
机械性心衰脱水装置及其控制装置 Download PDFInfo
- Publication number
- CN100571795C CN100571795C CNB2007101770028A CN200710177002A CN100571795C CN 100571795 C CN100571795 C CN 100571795C CN B2007101770028 A CNB2007101770028 A CN B2007101770028A CN 200710177002 A CN200710177002 A CN 200710177002A CN 100571795 C CN100571795 C CN 100571795C
- Authority
- CN
- China
- Prior art keywords
- blood
- ultrafiltrate
- heart failure
- pipeline
- mechanical heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010019280 Heart failures Diseases 0.000 title claims abstract description 63
- 210000004369 blood Anatomy 0.000 claims abstract description 145
- 239000008280 blood Substances 0.000 claims abstract description 145
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 97
- 230000001012 protector Effects 0.000 claims abstract description 41
- 238000001514 detection method Methods 0.000 claims abstract description 26
- 210000003462 vein Anatomy 0.000 claims abstract description 22
- 230000002093 peripheral effect Effects 0.000 claims abstract description 16
- 238000012545 processing Methods 0.000 claims abstract description 15
- 238000005303 weighing Methods 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 36
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 33
- 229960002897 heparin Drugs 0.000 claims description 33
- 229920000669 heparin Polymers 0.000 claims description 33
- 230000008569 process Effects 0.000 claims description 27
- 239000012528 membrane Substances 0.000 claims description 17
- 230000004087 circulation Effects 0.000 claims description 14
- 238000004159 blood analysis Methods 0.000 claims description 13
- 230000002159 abnormal effect Effects 0.000 claims description 12
- 230000002209 hydrophobic effect Effects 0.000 claims description 11
- 238000005259 measurement Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000017531 blood circulation Effects 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 238000012797 qualification Methods 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052753 mercury Inorganic materials 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 2
- 238000004088 simulation Methods 0.000 claims description 2
- 150000003384 small molecules Chemical class 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000009123 feedback regulation Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 10
- ZVKAMDSUUSMZES-NZQWGLPYSA-N OS II Natural products CC(=O)N[C@H]1[C@H](OC[C@@H](O)[C@@H](O)[C@@H](O)CO)O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O ZVKAMDSUUSMZES-NZQWGLPYSA-N 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000008358 core component Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 230000005622 photoelectricity Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 208000011316 hemodynamic instability Diseases 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- -1 polytetrafluoroethylenes Polymers 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- External Artificial Organs (AREA)
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007101770028A CN100571795C (zh) | 2007-11-08 | 2007-11-08 | 机械性心衰脱水装置及其控制装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007101770028A CN100571795C (zh) | 2007-11-08 | 2007-11-08 | 机械性心衰脱水装置及其控制装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101284152A CN101284152A (zh) | 2008-10-15 |
CN100571795C true CN100571795C (zh) | 2009-12-23 |
Family
ID=40056706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007101770028A Active CN100571795C (zh) | 2007-11-08 | 2007-11-08 | 机械性心衰脱水装置及其控制装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100571795C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102494173B (zh) * | 2011-12-15 | 2013-09-04 | 广州市美锐美容健康设备实业有限公司 | 数字化负压调节装置 |
CN109646740A (zh) * | 2019-02-22 | 2019-04-19 | 黄毅 | 一种自动控制排尿时机的接插件及包括其的导尿管组件 |
-
2007
- 2007-11-08 CN CNB2007101770028A patent/CN100571795C/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101284152A (zh) | 2008-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030216677A1 (en) | Biosensor for dialysis therapy | |
JPS618057A (ja) | 血液透析装置 | |
CN113975508B (zh) | 血液净化设备的故障确定方法、血液净化设备及存储介质 | |
CN108853622A (zh) | 一种血液透析故障检测报警装置 | |
EP2737918B1 (en) | Hemodialysis on-line port leak detection | |
CN100571795C (zh) | 机械性心衰脱水装置及其控制装置 | |
CN102895711A (zh) | 一种连续肾脏替代治疗装置 | |
CN100548392C (zh) | 血液净化装置 | |
CN201186074Y (zh) | 带置换液净化器的连续血液净化设备 | |
CN202637577U (zh) | 床旁连续血液透析滤过装置 | |
CN201085809Y (zh) | 通过外周静脉至静脉体外循环实现的机械性利水利钠装置 | |
CN101987210B (zh) | 血液滤过系统 | |
CN1548169A (zh) | 医用血液滤过机 | |
JP2010063644A (ja) | 血液浄化装置 | |
CN209075635U (zh) | 枸橼酸抗凝装置 | |
CN206334152U (zh) | 一种用于血液净化的调节系统 | |
CN207101561U (zh) | 一种便于安装的可检测液位的血液透析器 | |
CN205493928U (zh) | 具有检测报警功能的血液透析固定带 | |
CN106039446B (zh) | 一种可穿戴腹膜透析便携装置 | |
CN205515732U (zh) | 一种连续式crrt机器容量平衡装置 | |
CN109701098A (zh) | 一种便携透析治疗装置 | |
CN102641526A (zh) | 一种床旁连续血液透析滤过装置 | |
CN221579134U (zh) | 一种血液透析液体缓存器 | |
US20240102880A1 (en) | Leakage detection method and system, in particular for use in a blood treatment device | |
CN214843419U (zh) | 一种血液透析机脱水量的模拟检测系统 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING HEARTCARE MEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: FENG XINQING Effective date: 20150206 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100000 HAIDIAN, BEIJING TO: 102200 CHANGPING, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150206 Address after: 102200 No. 11 Huatong Road, Changping science and Technology Park, Beijing, Changping District Patentee after: Beijing Heartcare Medical Technology Co., Ltd. Address before: 100000 Xiyuan Hospital dormitory, 1 Xiyuan playground, Beijing, Haidian District 4-2-502 Patentee before: Feng Xinqing |